Skip to main content
NeuronFeed

Iambic Therapeutics vs Recursion

Which Healthcare AI tool is better in 2026?

Iambic Therapeutics

Leveraging AI technologies to accelerate the discovery and development of optimised medicines for challenging diseases.

Undisclosed

Recursion

Pioneering AI-driven solutions in drug discovery to radically improve lives.

$500M

Side-by-side

Verdict

Recursion is the more established option (raised $500M); pricing is comparable on both sides.

Metric Iambic Therapeutics Recursion
Taglinei Leveraging AI technologies to accelerate the discovery and development of optimised medicines for challenging diseases. Pioneering AI-driven solutions in drug discovery to radically improve lives.
Foundedi 2013🏆
HQi Salt Lake City, US
Employeesi 501-1000🏆
Neuron scorei 59 76🏆
Total fundingi Undisclosed $500M🏆
Latest roundi IPO · Apr 2021
Valuationi $2B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Enterprise · Contact sales Enterprise · Contact sales
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Iambic Therapeutics and Recursion.

Capability Iambic Therapeutics Recursion
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Iambic Therapeutics

  • Strong in AI Healthcare

🔵 Strengths of Recursion

  • Has raised more capital ($500M vs Undisclosed)
  • Higher Neuron score (76 vs 59)
  • Newer company (2013)

Which should you choose?

Choose Recursion if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Recursion if you want the most established option — it has raised $500M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Iambic Therapeutics vs Recursion — which is better?

It depends on your priority. Iambic Therapeutics is the leaner option; Recursion has broader feature depth. See the side-by-side table above.

Is Iambic Therapeutics cheaper than Recursion?

No — Recursion's cheapest paid plan is Enterprise · Contact sales, while Iambic Therapeutics's is Enterprise · Contact sales.

Do Iambic Therapeutics and Recursion offer free plans?

Iambic Therapeutics: Paid only. Recursion: Paid only.

Contextual paths to related AI startups, deals and rankings.